AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Embryonic development of multilineage hematopoiesis requires the precisely regulated expression of lineage-specific transcription factors, including AML-1 (encoded by Runx1; also known as CBFA-2 or PEBP-2alphaB). In vitro studies and findings in human diseases, including leukemias, myelodysplastic syndromes and familial platelet disorder with predisposition to acute myeloid leukemia (AML), suggest that AML-1 has a pivotal role in adult hematopoiesis. However, this role has not been fully uncovered in vivo because of the embryonic lethality of Runx1 knockout in mice. Here we assess the requirement of AML-1/Runx1 in adult hematopoiesis using an inducible gene-targeting method. In the absence of AML-1, hematopoietic progenitors were fully maintained with normal myeloid cell development. However, AML-1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development. AML-1 is thus required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells (HSCs) in adult hematopoiesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“Conditional knockout studies of mice demonstrate a specific role for RUNX-1 in megakaryocyte differentiation during adult stages of hematopoiesis”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“RUNX-1-deficient megakaryocytes have hypolobulated nuclei, underdeveloped cytoplasm, low DNA ploidy, and enhanced replating activity in semisolid medium culture assays.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
Citations
Cites
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“1b ), the cells defined by Lin −/lo IL-7Rα + Sca-1 lo c-Kit lo , previously reported to include common lymphocyte progenitors (CLPs”
BackgroundLong-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641 · cited 1×
“Here we assess the requirement of AML-1/ Runx1 in adult hematopoiesis using an inducible gene-targeting metho”
MethodWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“In vitro studies and findings in human diseases, including leukemia”
BackgroundTaniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S.-C., Komori, T., Ito, Y., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01111-x · Cited by 730
Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674
North, T. E., de Bruijn, M. F. T. R., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder, M., Dzierzak, E., & Speck, N. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00296-0 · Cited by 583
Cited by
Items 201–300 of 595
Choi, Y., Elagib, K. E., Delehanty, L. L., & Goldfarb, A. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2944 · Cited by 56
“Importantly, the erythroid differentiation program occurs in a RUNX-independent manner (12), i.”
BackgroundAcute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells
Wesely, J., Kotini, A. G., Izzo, F., Luo, H., Yuan, H., Sun, J., Georgomanoli, M., Zviran, A., Deslauriers, A. G., Dusaj, N. N., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107688 · Cited by 57
“Although we did not directly test the effect of RUNX1 KD in normal HSCs here, several lines of evidence suggest that RUNX1 complete deletion, depletion, or haploinsufficiency (as we mimic here by 50% shRNA KD) does not impair HSC function in adult mice or humans (Chen et al., 2009; Ichikawa et al., 2004).”
BackgroundFerjoux, G., Augé, B., Boyer, K., Haenlin, M., & Waltzer, L. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.03.010 · Cited by 67
“, 1996) as well as for lymphocyte and megakaryocyte differentiation in mice (Ichikawa et al., 2004).”
BackgroundWong, W. F., Kohu, K., Nakamura, A., Ebina, M., Kikuchi, T., Tazawa, R., Tanaka, K., Kon, S., Funaki, T., Sugahara–Tobinai, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102991 · Cited by 61
“To examine the function of Runx1 in naive CD4 T cells, Runx1 expression in CD4 T cells was disrupted by breeding Runx1 mice, in which the Runx1 exon 5 is flanked by the loxP sites (details of targeting vector were described previously) (22), with CD4-Cre-tg mice (23) to yield Runx1;CD4-Cre-tg mice (hereafter referred…”
BackgroundMethodSelf-citationRunx1 promotes B-cell survival and lymphoma development
Blyth, K., Slater, N., Hanlon, L., Bell, M., Mackay, N. A., Stewart, M. A., Neil, J. C., & Cameron, E. R. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.01.013 · Cited by 54
Levay, K., & Slepak, V. Z. (2007) · Journal of Clinical Investigation · doi:10.1172/jci27465 · Cited by 60
Himes, S. R., Cronau, S. L., Mulford, C., & Hume, D. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208657 · Cited by 57
Wang, W., Schwemmers, S., Hexner, E. O., & Pahl, H. L. (2010) · Blood · doi:10.1182/blood-2009-11-254664 · Cited by 63
Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesisPreprint
Liu, X.-T., Zhang, Q., Zhang, D.-E., Zhou, C., Xing, H., Tian, Z., Rao, Q., Wang, M., & Wang, J. (2008) · Nature Precedings · doi:10.1038/leu.2008.350 · Cited by 65
Aneja, K. K., Jalagadugula, G. S., Mao, G., Singh, A., & Rao, A. K. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04154.x · Cited by 57
“RUNX1 is a transcription factor that plays a major role in hematopoiesis and megakaryopoiesis [22-24].”
BackgroundSatpathy, A. T., Briseño, C. G., Cai, X., Michael, D. G., Chou, C., Hsiung, S., Bhattacharya, D., Speck, N. A., & Egawa, T. (2014) · Blood · doi:10.1182/blood-2013-11-539643 · Cited by 63
Tachibana, M., Tenno, M., Tezuka, C., Sugiyama, M., Yoshida, H., & Taniuchi, I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000162 · Cited by 57
Houwerzijl, E. J., Blom, N. R., van der Want, J. J. L., Louwes, H., Esselink, M. T., Smit, J. W., Vellenga, E., & de Wolf, J. T. M. (2004) · Blood · doi:10.1182/blood-2004-06-2108 · Cited by 63
Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium
Lie‐A‐Ling, M., Marinopoulou, E., Lilly, A. J., Challinor, M., Patel, R., Lancrin, C., Kouskoff, V., & Lacaud, G. (2018) · Development · doi:10.1242/dev.149419 · Cited by 61
“Although RUNX1 is not essential for survival once the adult blood system has been established, its absence or the reduction of its level still results in perturbations in the specification and differentiation of multiple blood lineages (Chen et al., 2009; Growney et al., 2005; Ichikawa et al., 2004).”
BackgroundChan, W.-I., Hannah, R. L., Dawson, M. A., Pridans, C., Foster, D., Joshi, A., Göttgens, B., Van Deursen, J. M., & Huntly, B. J. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05830-11 · Cited by 51
“These data are reminiscent of the relative subtle defects in HSC function after homeostatic loss of critical developmental regulators of hematopoiesis, such as Scl and Runx1 (16, 26).”
BackgroundInfluentialGATA Transcription Factors in Hematologic Disease
Cantor, A. B. (2005) · International Journal of Hematology · doi:10.1532/ijh97.04180 · Cited by 55
“out of Runx-1 in mice leads to thrombocytopenia due to a block in megakaryocytic maturation [ 56 ].”
BackgroundPeterson, L. F., Boyapati, A., Ranganathan, V., Iwama, A., Tenen, D. G., Tsai, S., & Zhang, D.-E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10205-10219.2005 · Cited by 51
“Two AML1 C-terminal deletion constructs—AML1(1-289) and AML1(1213)—were used in this study.”
BackgroundMethodInfluentialExpression of B Cell-Specific Activator Protein/PAX5 in Acute Myeloid Leukemia With t(8;21)(q22;q22)
Valbuena, J. R., Medeiros, L. J., Rassidakis, G. Z., Hao, S., Wu, C., Chen, L., & Lin, P. (2006) · American Journal of Clinical Pathology · doi:10.1309/lg0q-0vxy-betj-4vhe · Cited by 51
“Expression of B Cell–Specific Activator Protein/PAX5 in Acute Myeloid Leukemia With t(8;21)(q22;q22)”
BackgroundMethodInfluentialAML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells
Satoh, Y., Matsumura, I., Tanaka, H., Ezoe, S., Fukushima, K., Tokunaga, M., Yasumi, M., Shibayama, H., Mizuki, M., Era, T., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804768200 · Cited by 61
Runx family genes, niche, and stem cell quiescence
Wang, C. Q., Jacob, B., Nah, G. S. S., & Osato, M. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.01.006 · Cited by 57
Shiba, N., Hasegawa, D., Park, H., Murata, C., Sato‐Otsubo, A., Ogawa, C., Manabe, A., Arakawa, H., Ogawa, S., & Hayashi, Y. (2011) · Blood · doi:10.1182/blood-2011-02-333435 · Cited by 52
Self-citationBrady, G., Whiteman, H. J., Spender, L. C., & Farrell, P. J. (2009) · Journal of Virology · doi:10.1128/jvi.00216-09 · Cited by 50
“by the RUNX family in normal B-cell development (9, 18).”
BackgroundMegakaryocyte polyploidization: role in platelet production
Vainchenker, W., & Raslová, H. (2019) · Platelets · doi:10.1080/09537104.2019.1667497 · Cited by 54
Trisomy of chromosome 21 in leukemogenesis
Izraeli, S., Rainis, L., Hertzberg, L., Smooha, G., & Birger, Y. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.04.004 · Cited by 49
Iizuka, H., Kagoya, Y., Kataoka, K., Yoshimi, A., Miyauchi, M., Taoka, K., Kumano, K., Yamamoto, T., Hotta, A., Arai, S., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.004 · Cited by 53
Self-citationC-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells
Satoh, Y., Matsumura, I., Tanaka, H., Harada, H., Harada, Y., Matsui, K., Shibata, M., Mizuki, M., & Kanakura, Y. (2011) · Leukemia · doi:10.1038/leu.2011.202 · Cited by 51
Guo, T., Wang, X., Qu, Y., Yin, Y., Jing, T., & Zhang, Q. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2306-9759.2015.02.01 · Cited by 65
“In RUNX1-deficient BM megakaryocytic maturation was inhibited (21).”
BackgroundStat1-mediated cytoplasmic attenuation in osteoimmunology
Takayanagi, H., Kim, S., Koga, T., & Taniguchi, T. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20316 · Cited by 47
Starck, J., Weiss‐Gayet, M., Gonnet, C., Guyot, B., Vicat, J.-M., & Morlé, F. (2010) · Blood · doi:10.1182/blood-2010-02-270405 · Cited by 57
Tracking Mesoderm Formation and Specification to the Hemangioblast in Vitro
Lacaud, G., Keller, G. M., & Kouskoff, V. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.09.004 · Cited by 55
Runx Transcription Factors in T Cells—What Is Beyond Thymic Development?
Korinfskaya, S., Parameswaran, S., Weirauch, M. T., & Barski, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701924 · Cited by 58
Teitell, M. A., & Mikkola, H. K. A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000205155.26315.c7 · Cited by 52
“Surprisingly, crossing mice that harbored loxP site flanked Runx1 loci with an interferoninducible MxCre deleting strain showed that Runx1 is not critical for the function of definitive HSCs in the adult, yet continues to be essential in the lymphoid and mega-karyocyte lineages (23,24).”
BackgroundLeukemia and hematopoietic stem cells: Balancing proliferation and quiescence
Jude, C. D., Gaudet, J., Speck, N. A., & Ernst, P. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5549 · Cited by 50
Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice
Lam, K., Muselman, A., Du, R., Harada, Y., Scholl, A. G., Yan, M., Matsuura, S., Weng, S., Harada, H., & Zhang, D.-E. (2014) · Blood · doi:10.1182/blood-2014-02-554543 · Cited by 46
“Conditional deletion of Runx1 in mice has allowed for the study of its role in HSPCs becausemice that are null forRunx1 display embryonic lethality.(1,2,17,18) Interestingly, one of the most striking phenotypes in Runx1 conditional knockout mice is a marked expansion of their HSPCs and myeloid progenitors.”
BackgroundRUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis
Rossetti, S., & Sacchi, N. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011566 · Cited by 51
“Runx1 deficient adult mice also showed impaired lymphoid and megakaryocytic differentiation, a reduced number of lymphoid progenitors, and thrombocytopenia [52,53].”
BackgroundT cell acute lymphoblastic leukemia arising from familial platelet disorder
Nishimoto, N., Imai, Y., Ueda, K., Nakagawa, M. M., Shinohara, A., Ichikawa, M., Nannya, Y., & Kurokawa, M. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0612-y · Cited by 48
“As we have previously reported, RUNX1 plays a definite role in the development of precursor T cells [6].”
BackgroundSelf-citationRUNX1 cooperates with FLT3-ITD to induce leukemia
Behrens, K., Maul, K., Tekin, N. S., Kriebitzsch, N., Indenbirken, D., Prassolov, V., Müller, U., Serve, H. L., Cammenga, J., & Stocking, C. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160927 · Cited by 48
“Runx1 inactivation in mouse models has demonstrated critical functions in several blood lineages: maturation of megakaryocytes (Meg), initiation and progression of B cell development, and stage-specific development of T cells (Ichikawa et al., 2004; Collins et al., 2009; Wong et al., 2011b; Niebuhr et al., 2013).”
BackgroundRUNX transcription factors at the interface of stem cells and cancer
Deltcheva, E. M., & Nimmo, R. A. (2017) · Biochemical Journal · doi:10.1042/bcj20160632 · Cited by 53
Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation
Hamelin, V., Letourneux, C., Roméo, P., Porteu, F., & Gaudry, M. (2005) · Blood · doi:10.1182/blood-2005-07-2953 · Cited by 56
RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia
Gialesaki, S., Bräuer-Hartmann, D., Issa, H., Bhayadia, R., Alejo-Valle, O., Verboon, L., Schmell, A. L., Laszig, S., Regényi, E., Schuschel, K., et al. (2022) · Blood · doi:10.1182/blood.2022017619 · Cited by 51
A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation
Wang, C., Tu, Z., Cai, X., Wang, W., Davis, A. K., Nattamai, K., Paranjpe, A., Dexheimer, P. J., Wu, J., Huang, F. L., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008591 · Cited by 51
“Thus, Runx1 knockout in mice causes a defect in MK differentiation and thrombocytopenia among other blood differentiation defects, consistent with previous reports.(14,19,21) Runx1 deletion affects direct differentiation from MK-HSCs to MKs We focused on the MK-HSC subpopulation, which is at the top of hematopoiesis h…”
BackgroundResultYokota, A., Huo, L., Lan, F., Wu, J., & Huang, G. (2020) · PubMed Central · doi:10.14348/molcells.2019.0252 · Cited by 67
“In adult hematopoiesis, however, it is dispensable for the maintenance of HSCs but required for megakaryocyte maturation and T lymphocyte-lineage differentiation (Ichikawa et al., 2004; Taniuchi et al., 2002).”
BackgroundThe transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis
Guo, Z., Zhou, K., Wang, Q., Huang, Y., Ji, J., Peng, Y., Zhang, X., Zheng, T., Zhang, Z., Chong, D., et al. (2021) · Cancer Science · doi:10.1111/cas.15045 · Cited by 48
A crucial role for the homeodomain transcription factor Hhex in lymphopoiesis
Jackson, J. T., Nasa, C., Shi, W., Huntington, N. D., Bogue, C. W., Alexander, W. S., & McCormack, M. P. (2014) · Blood · doi:10.1182/blood-2014-06-579813 · Cited by 44
The Thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis
Chou, F., & Mulloy, J. C. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23089 · Cited by 44
“In addition, Runx1 inducible knock-out in the adult hematopoietic system showed no effect on HSC or increased HSC activity, while THPO or MPL knock-out is associated with continuous loss of HSC phenotypes [Ichikawa et al., 2004].”
BackgroundMicroRNAs as regulators and effectors of hematopoietic transcription factors
Kim, M., Civin, C. I., & Kingsbury, T. J. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1537 · Cited by 48
“Previously, Runx1-deficient mice demonstrated that RUNX1 plays important roles in megakaryocytopoiesis, myelopoiesis, and lymphopoiesis (Growney et al., 2005; Hayashi et al., 2000; Ichikawa et al., 2004; Taniuchi et al., 2002).”
BackgroundRunx1 exon 6–related alternative splicing isoforms differentially regulate hematopoiesis in mice
Komeno, Y., Yan, M., Matsuura, S., Lam, K., Lo, M., Huang, Y.-J., Tenen, D. G., Downing, J. R., & Zhang, D. (2014) · Blood · doi:10.1182/blood-2013-08-521252 · Cited by 52
Liu, J., Park, E., & Jo, M. (2009) · Endocrinology · doi:10.1210/en.2008-1527 · Cited by 49
The genetics of human hematopoiesis and its disruption in disease
Bao, E. L., Cheng, A. N., & Sankaran, V. G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910316 · Cited by 42
“Given the challenges of studying Runx1 in mice due to early embryonic lethality (Ichikawa et al, 2004), human genetic studies of FPDMM have provided powerful insights into the roles of the RUNX1 TF in normal and malignant hematopoiesis.”
BackgroundGatekeeper function of the RUNX1 transcription factor in acute leukemia
Niebuhr, B., Fischer, M., Täger, M., Cammenga, J., & Stocking, C. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.07.018 · Cited by 48
Shinohara, A., Imai, Y., Nakagawa, M. M., Takahashi, T., Ichikawa, M., & Kurokawa, M. (2014) · Stem Cells · doi:10.1002/stem.1588 · Cited by 48
Self-citationPost-translational modifications of Runx1 regulate its activity in the cell
Wang, L., Huang, G., Zhao, X., Hatlen, M. A., Vu, L., Liu, F., & Nimer, S. D. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.03.005 · Cited by 50
“RUNX1 is required for megakaryocytic maturation in adult hematopoiesis[18], and sustained ERK1/2 activation is required for cell differentiation into megakaryocytic cells[19–21] implying that RUNX1 phosphorylation by ERK1/2 may be critical for megakaryocytic differentiation.”
BackgroundSimon, L., Lavallée, V., Bordeleau, M.-È., Krošl, J., Baccelli, I., Boucher, G., Lehnertz, B., Chagraoui, J., MacRae, T., Ruel, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1259 · Cited by 44
“RUNX1 is amaster regulator of definitive hematopoiesis where it regulates the differentiation of myeloid, megakaryocytic, and lymphocytic lineage progenitors (1, 2).”
BackgroundRunx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells
Omatsu, Y., Aiba, S., Maeta, T., Higaki, K., Aoki, K., Watanabe, H., Kondoh, G., Nishimura, R., Takeda, S., Chung, U., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30266-y · Cited by 50
Morrow, M., Samanta, A., Kioussis, D., Brady, H. J. M., & Williams, O. (2007) · Oncogene · doi:10.1038/sj.onc.1210227 · Cited by 44
“Conditional knockout studies have demonstrated that AML1 is required for normal B-cell development (Ichikawa et al., 2004; Growney et al., 2005).”
BackgroundZhen, T., Cao, Y., Ren, G., Zhao, L., Hyde, R. K., Lopez, G., Feng, D., Alemu, L., Zhao, K., & Liu, P. (2020) · Blood · doi:10.1182/blood.2020007747 · Cited by 44
Kurokawa, M. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06070 · Cited by 44
Self-citationBehrens, K., Triviai, I., Schwieger, M., Tekin, N. S., Alawi, M., Spohn, M., Indenbirken, D., Ziegler, M., Müller, U., Alexander, W. S., et al. (2016) · Blood · doi:10.1182/blood-2015-09-668129 · Cited by 45
“Indeed the sole, characterized myeloid defect in Runx1-deficient mice is impaired Meg maturation.(35,38) We reasoned that defects in cell fate decision in the earlyHSC/MPP compartment in Runx1-deficient mice should read out in the downstream MP compartment, which has only been superficially examined in previous studie…”
BackgroundResultRabenhorst, U., Thalheimer, F. B., Gerlach, K., Kijonka, M., Böhm, S., Krause, D. S., Vauti, F., Arnold, H.-H., Schroeder, T., Schnütgen, F., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.038 · Cited by 42
“Although transcription factors essential for the establishment of definitive LT-HSCs in fetal tissues have been identified, such as RUNX1 (Samokhvalov et al., 2007) and TAL1 (Mikkola et al., 2003; Schlaeger et al., 2005), the transcriptional network that governs the self-renewal and expansion programs in LT-HSCs remai…”
Wong, W. F., Kurokawa, M., Satake, M., & Kohu, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166694 · Cited by 46
Self-citationLiakhovitskaia, A., Gribi, R., Stamateris, E., Villain, G., Jaffredo, T., Wilkie, R., Gilchrist, D. S., Yang, J., Ure, J., & Medvinsky, A. (2009) · Stem Cells · doi:10.1002/stem.71 · Cited by 43
Transcription factor‐mediated reprogramming toward hematopoietic stem cells
Ebina, W., & Rossi, D. J. (2015) · The EMBO Journal · doi:10.15252/embj.201490804 · Cited by 43
“Intriguingly, however, conditional loss of Runx1 in the adult hematopoietic system only impairs megakaryocytic and lymphoid differentiation with minimal impact on HSC activity (Ichikawa et al , 2004; Cai et al , 2011).”
Draper, J. E., Sroczyńska, P., Tsoulaki, O., Leong, H. S., Fadlullah, M. Z. H., Miller, C. J., Kouskoff, V., & Lacaud, G. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005814 · Cited by 43
“megakaryocytic maturation and platelet production [16,17].”
Diversity, function, and transcriptional regulation of gut innate lymphocytes
Rankin, L. C., Groom, J., Mielke, L. A., Seillet, C., & Belz, G. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00022 · Cited by 47
“Runx is essential for the differentiation of several hematopoietic cell lineages including B cells, NK T cells, and CD8+ T cells (Okuda et al., 1996; Ichikawa et al., 2004; Egawa et al., 2005; Setoguchi et al., 2008).”
BackgroundHaploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice
Yamashita, N., Osato, M., Huang, L., Yanagida, M., Kogan, S. C., 岩崎, 正., Nakamura, T., Shigesada, K., Asou, N., & Ito, Y. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05793.x · Cited by 41
“This phenotype was further confirmed in conditional Runx1 knockout mice ( Ichikawa et al, 2004 ).”
BackgroundLi, F., Liu, J., Park, E., Jo, M., & Curry, T. E. (2009) · Endocrinology · doi:10.1210/en.2008-1650 · Cited by 41
Marsman, J., O’Neill, A. C., Kao, B., Rhodes, J. M., Meier, M., Antony, J., Mönnich, M., & Horsfield, J. A. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.11.007 · Cited by 42
Goldfarb, A. N. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22142 · Cited by 47
“Inducible deletion of RUNX1 in adult mice, RUNX1D/D, causes a rapid and prolonged fivefold drop in peripheral blood platelet counts, with minimal effects on red cell or neutrophil numbers [Ichikawa et al., 2004; Growney et al., 2005].”
BackgroundInfluentialDu, L., Xu, J., Li, X., Ma, N., Liu, Y., Peng, J., Osato, M., Zhang, W., & Wen, Z. (2011) · Development · doi:10.1242/dev.054536 · Cited by 41
“For example, Tal1 and Runx1 are found to be necessary for the initiation, but dispensable for the maintenance of, hematopoietic stem cells in mice (Mikkola et al., 2003; Ichikawa et al., 2004).”
BackgroundYe, B., Li, C., Yang, Z., Wang, Y., Hao, J., Wang, L., Li, Y., Du, Y., Hao, L., Liu, B., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20141123 · Cited by 42
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer
Doffo, J., Bamopoulos, S. A., Köse, H., Orben, F., Zang, C., Pons, M., den Dekker, A. T., Brouwer, R. W. W., Baluapuri, A., Habringer, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105691119 · Cited by 38
“As has been shown in mouse models, knockouts of any of the three RUNX transcription factors exhibit significant developmental defects: RUNX1 plays an important role in hematopoiesis (18), RUNX2 plays an important role in bone development (19), and RUNX3 plays an important role in the gastrointestinal tract (20) and in…”
BackgroundMechanisms of self-renewal in hematopoietic stem cells
Wang, Z., & Ema, H. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1919-5 · Cited by 42
Fukushima‐Nakase, Y., Naoe, Y., Taniuchi, I., Hosoi, H., Sugimoto, T., & Okuda, T. (2005) · Blood · doi:10.1182/blood-2004-08-3372 · Cited by 38
The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells
Staber, P. B., Zhang, P., Ye, M., Welner, R. S., Levantini, E., Di Ruscio, A., Ebralidze, A. K., Bach, C., Zhang, H., Zhang, J., et al. (2014) · Blood · doi:10.1182/blood-2014-01-550855 · Cited by 36
“Previous reports of Runx1 function in HSCs have been inconsistent, probably due to partial compensatory effects of other Runx family members.21-24 Here we show that Runx1 deletion led to Runx3 upregulation in HSCs.”
BackgroundInfluentialLessons in platelet production from inherited thrombocytopenias
Pecci, A., & Balduini, C. L. (2014) · British Journal of Haematology · doi:10.1111/bjh.12752 · Cited by 41
“Moreover, Runx1-deleted mice have thrombocytopenia that is associated with remarkable abnormalities of both polyploidization and cytoplasmic maturation of BM Mks (Ichikawa et al, 2004).”
BackgroundZang, C., Luyten, A., Chen, J., Liu, X. S., & Shivdasani, R. A. (2016) · Scientific Reports · doi:10.1038/srep30255 · Cited by 39
Transcription factor interplay during Drosophila haematopoiesis
Waltzer, L., Gobert, V., Osman, D., & Haenlin, M. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.093054lw · Cited by 40
Kawazu, M., Asai, T., Ichikawa, M., Yamamoto, G., Saito, T., Goyama, S., Mitani, K., Miyazono, K., Chiba, S., Ogawa, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3526 · Cited by 40
Self-citationRunx factors launch T cell and innate lymphoid programs via direct and gene network-based mechanisms
Shin, B., Zhou, W., Wang, J., Gao, F., & Rothenberg, E. V. (2023) · Nature Immunology · doi:10.1038/s41590-023-01585-z · Cited by 34
Potts, K. S., Sargeant, T., Dawson, C. A., Josefsson, E. C., Hilton, D. J., Alexander, W. S., & Taoudi, S. (2015) · Blood · doi:10.1182/blood-2014-12-616607 · Cited by 34
Transcriptional Auto-Regulation of RUNX1 P1 Promoter
Martínez, M., Hinojosa, M., Trombly, D. J., Morín, V., Stein, J. L., Stein, G. S., Javed, A., & Gutierrez, S. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149119 · Cited by 39
“Conditional deletion of RUNX1 gene in hematopoietic organs revealed that in early postnatal life RUNX1 is not essential for maturation of myeloid lineage cells or the maintenance of hematopoietic stem cells [14].”
BackgroundThe Roles of RUNX Family Proteins in Development of Immune Cells.
Seo, W., & Taniuchi, I. (2020) · PubMed Central · doi:10.14348/molcells.2019.0291 · Cited by 38
“Several studies have shown that RUNX1 protein has pivotal roles in priming B lymphoid lineage (Growney et al., 2005; Ichikawa et al., 2004), specifically by working along with EBF1 (Maier et al.”
BackgroundThe role of Runx1/AML1 and Evi‐1 in the regulation of hematopoietic stem cells
Kumano, K., & Kurokawa, M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21953 · Cited by 37
“We confirmed the increase in KSL cells but found an increase in the number of quiescent side population cells and KSL cells in G0 in the absence of Runx1 together with increased competitive repopulation (Ichikawa et al., 2008).”
BackgroundSelf-citationRUNX factors in development: Lessons from invertebrate model systems
Braun, T., & Woollard, A. C. S. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.05.001 · Cited by 40
Matsumura, T., Nakamura‐Ishizu, A., Muddineni, S. S. N. A., Tan, D. Q., Wang, C. Q., Tokunaga, K., Tirado-Magallanes, R., Sian, S., Benoukraf, T., Okuda, T., et al. (2020) · Blood · doi:10.1182/blood.2019004292 · Cited by 34
Estevez, B., Borst, S., Jarocha, D. J., Sudunagunta, V. S., Gonzalez, M. V., Garifallou, J. P., Hakonarson, H. H., Gao, P., Tan, K., Liu, P., et al. (2021) · Blood · doi:10.1182/blood.2020006389 · Cited by 33
Tsuzuki, S., & Seto, M. (2011) · Blood · doi:10.1182/blood-2011-06-362277 · Cited by 37
Inherited thrombocytopenias: an approach to diagnosis and management
Geddis, A. E. (2012) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2012.01454.x · Cited by 37
“Although RUNX1 is well known for its role in myeloid malignancy, it is also critical for the differentiation of megakaryocytes and T and B cells [59].”
BackgroundLoss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF
Nishimoto, N., Arai, S., Ichikawa, M., Nakagawa, M. M., Goyama, S., Kumano, K., Takahashi, T., Kamikubo, Y., Imai, Y., & Kurokawa, M. (2011) · Blood · doi:10.1182/blood-2010-10-315440 · Cited by 35
Self-citationDeregulated transcription factors in leukemia
Shima, Y., & Kitabayashi, I. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0905-9 · Cited by 36
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications
Gonzales, F., Barthélémy, A., Peyrouze, P., Fenwarth, L., Preudhomme, C., Duployez, N., & Cheok, M. H.-C. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1915991 · Cited by 43
“roles in the maintenance of lineage-committed cells in human hematopoiesis [74].”
BackgroundMoussa, O., LaRue, A. C., Abangan, R. S., Williams, C. R., Zhang, X. K., Masuya, M., Gong, Y. Z., Spyropoulos, D. D., Ogawa, M., Gilkeson, G. S., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01112-09 · Cited by 35
Chinen, Y., Taki, T., Nishida, K., Shimizu, D., Okuda, T., Yoshida, N., Kobayashi, C., Koike, K., Tsuchida, M., Hayashi, Y., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210857 · Cited by 37
“Furthermore, it was reported that AML1 also plays an important role in T- and B-cell differentiation, because AML1-deficient bone marrow increased defective T- and B-lymphocyte development (Ichikawa et al., 2004).”
BackgroundNovel function of FAXDC2 in megakaryopoiesis
Jin, Q., Ren, Y., Wang, M., Suraneni, P. K., Li, D., Crispino, J. D., Fan, J., & Huang, Z. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.87 · Cited by 35
Runx3 deficiency results in myeloproliferative disorder in aged mice
Wang, C. Q., Motoda, L., Satake, M., Ito, Y., Taniuchi, I., Tergaonkar, V., & Osato, M. (2013) · Blood · doi:10.1182/blood-2012-10-460618 · Cited by 31
“Runx1 regulates the expression of stemness- and niche-related factors, such as Bmi1, Cxcr4 and integrin α2, deregulation of which in adult Runx1 knockout (KO) mice led to an expanded hematopoietic stem/progenitor cell (HSPC) compartment and subsequent stem cell exhaustion.(6-12) In addition, adult Runx1 KO mice show a…”
BackgroundZebrafish Cancer Predisposition Models
Kobar, K., Collett, K., Prykhozhij, S. V., & Berman, J. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660069 · Cited by 39
Increased Dosage of the RUNX1/AML1 Gene: A Third Mode of RUNX Leukemia?
Osato, M., & Ito, Y. (2005) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v15.i3.40 · Cited by 37
Levantini, E., Lee, S., Radomska, H. S., Hetherington, C. J., Alberich-Jordà, M., Amabile, G., Zhang, P., Gonzalez, D. A., Zhang, J., Bassères, D. S. D. S., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.285 · Cited by 35
“…of HSCs and the establishment of a blood- cell-specific gene expression programme in the embryo is RUNX1 (Okuda et al, 1996; Okada et al, 1998; Cai et al, 2000; Ichikawa et al, 2004a, b, 2008; Growney et al, 2005; Putz et al, 2006; Chen et al, 2009; Hoogenkamp et al, 2009; Jacob and Osato, 2009).”
BackgroundDraper, J. E., Sroczyńska, P., Leong, H. S., Fadlullah, M. Z. H., Miller, C. J., Kouskoff, V., & Lacaud, G. (2017) · Blood · doi:10.1182/blood-2016-06-723635 · Cited by 34
Normal and malignant megakaryopoiesis
Wen, Q., Goldenson, B., & Crispino, J. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002043 · Cited by 43
“61 Putz, G. et al. (2006) AML1 deletion in adult mice causes splenomegaly and lymphomas.”
Background
Metadata
- Authors
- Ichikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., Ogawa, S., & Kurokawa, M.
- Affiliations
- The University of Tokyo (JP)
- Inoue Hospital (JP)
- Joslin Diabetes Center (US)
- Dokkyo University (JP)
- Corresponding author
- Ogawa, Seishi
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-02-15
- Volume
- 10
- Issue
- 3
- Pages
- 299-304
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101518963
- Cited by
- 596
- References
- 29
- Citations by year
- 2026: 11 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 28 · 2020: 18 · 2019: 22 · 2018: 20 · 2017: 33 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 29 · 2012: 27
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- RUNX1, lymphocyte differentiation, T cell development, B cell development, hematopoietic stem cells, hematopoietic progenitor cells, adult hematopoiesis, myelodysplastic syndrome
- MeSH terms
- Adult, Animals, Bone Marrow Cells, Cell Differentiation, DNA-Binding Proteins, Hematopoiesis, Hematopoietic Stem Cells, Humans, Lymphocytes, Megakaryocytes, Mice, Inbred Strains, Mice, Transgenic, Proto-Oncogene Proteins, Transcription Factors, Gene Targeting, Cell Lineage, Cell Size, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.